NeuroSense Therapeutics is progressing its ALS treatment PrimeC through regulatory steps in Canada and the U.S., targeting a Canadian New Drug Submission by December 2026. The company reported positive Phase 2b trial results showing significant survival benefits and biomarker improvements, reinforcing PrimeC's potential to slow ALS progression. NeuroSense is optimizing its U.S. development strategy, including discussions with the FDA on approval pathways, while pursuing financing and strategic partnerships to support ongoing development. These advances highlight NeuroSense's commitment to addressing the unmet need in ALS treatment.
NeuroSense Therapeutics business update is presented here with Pluang's health sector market data as of Sep 26, 2026 03:22 WIB. Of 100 priced health-sector US stocks tradable on Pluang, 53 rose and 47 fell today. Notable movers include Tenet Healthcare Corporation (THC) at USD 260.26 with a 1-day change of +4.30%, Recursion Pharmaceuticals Inc (RXRX) at USD 3.74 down -3.86%, and Enveric Biosciences Inc (ENVB) at USD 1.49 down -3.56%.
Alphabet is predicted to announce that its Google Cloud division will achieve revenue growth exceeding 100% in its upcoming report on October 28. This significant growth highlights the expanding importance of cloud services in Alphabet's business str...
Chery Auto is showcasing its purpose-built Level 4 (L4) self-driving Robotaxi at its 2026 Global User Summit in Wuhu, China, and signing a strategic cooperation agreement with UAE-based company K2. The Robotaxi, designed from the ground up for autono...
A Bitcoin long position on the decentralized futures platform Hyperliquid, leveraged 40 times and valued at nearly $98 million, is close to liquidation with Bitcoin trading just 1.61% above the liquidation price. The position, holding over 1,200 BTC,...
The Ultra (UOS) cryptocurrency token experienced a sharp 11.05% decline within a 15-minute period on October 18, bringing its price close to the lower end of its 24-hour trading range at $0.002505. Over the full day, UOS lost 6.37%, and it also decli...
Charles Schwab is enabling eligible clients to transfer Bitcoin (BTC) and Ether (ETH) between its platform and external wallets, expanding beyond just holding crypto within investment accounts. This phased rollout currently supports only Bitcoin and ...
